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ABSTRACT
Objective: The aim of the present study was to validate a Swedish transla-
tion of the Gastrointestinal Quality of Life Index (GIQLI) questionnaire in
patients with gallstone disease.
Methods: Sensitivity to change, internal consistency, and test–retest sta-
bility were tested in 187 consecutive patients who underwent planned
cholecystectomy. Construct validity was assessed by comparing the GIQLI
score with the bodily pain scale of SF-36 and four single-item questions in
a separate group of 104 patients.
Results: A signiﬁcant increase in all ﬁve domains as well as in the
overall GIQLI score 6 months after surgery (all P < 0.05) was seen.
All ﬁve domains correlated signiﬁcantly with other measures of gallstone-
related symptoms except one single-item question. Intraclass correlations
ranged from 0.62 to 0.87. Cronbach’s alpha ranged from 0.77 to
0.89.
Conclusion: The Swedish translation of GIQLI has a high validity
and reliability for assessing the impact of gallstones on quality of
life.
Keywords: cholecystectomy, gallstone, gastrointestinal symptoms, quality
of life, reliability, validity.
Background
The prevalence of gallstones is very high throughout the Western
world, especially in the older population [1]. The manifestation
of gallstones varies from no symptoms at all to frequent attacks
of intense biliary colic with a profound inﬂuence on the quality of
life and potentially serious complications, such as acute chole-
cystitis, pancreatitis, and cholangitis.
As the indications for surgical treatment of gallstones is
a matter of controversy, a reliable instrument for assessing
gallstone-related symptoms is crucial. The Gastrointestinal
Quality of Life Index (GIQLI) was developed in German and has
been translated into English [2]. It includes 36 items divided
between ﬁve domains: symptoms, physical dysfunction, emo-
tional dysfunctions, social dysfunction, and a single-item question
on the effect of medical treatment. Each domain includes 4 to 19
items. It has been applied in patients with various gastrointestinal
disorders, including gastroesophageal reﬂux disease [3], gallstone-
related symptoms [4], and irritable bowel syndrome [5].
The aim of the present study was to validate a Swedish
translation of the GIQLI questionnaire as an instrument for
assessing the impact of gallstone-related symptoms on health-
related quality of life. The validation was performed by compar-
ing the outcome from GIQLI with that from SF-36 and four
single-item questions, by a factor analysis and by assessing the
sensitivity to change of the instrument.
Material and Methods
The GIQLI includes 36 items with ﬁve answer categories for each
item. By rating the answers from 0 to 4, a global score ranging
from 0 to 144 can be estimated. Scores can also be counted for
each of the domains.
The study was based on a translation of the GIQLI ques-
tionnaire from German into Swedish made by two independent
persons with Swedish as their native language and with a ﬂuent
knowledge of German. The two versions were compared and a
ﬁnal version was produced, taking both versions into account.
The Swedish translation was retranslated back to German by
an independent translator. The retranslation into German did
not show any major deviations from the original version. The
retranslated version was also examined by Ernst Eypasch,
the developer of GIQLI, who did not ﬁnd any deviations of
importance.
Tests for reliability and validity of the questionnaire were
made on a cohort of patients aged 18 years or older undergoing
elective cholecystectomy in the county of Uppsala, Sweden. The
patients were requested to ﬁll in the GIQLI questionnaire, SF-36,
and four single-item questions before the operation and 6, 12,
and 15 months postoperatively. In addition, they were requested
to evaluate their pain using a visual analogue scale (VAS). The
VAS has previously been validated as an instrument for measur-
ing chronic pain [6].
Reliability
Test–retest stability was tested by asking the patients operated on
between January 1 and August 31, 2005 to answer the question-
naire 3 months apart after 1 year had elapsed since surgery. The
interval of 3 months was chosen as interval as the time elapsed
since surgery was expected to provide a stabile period disease
activity. The interval was also long enough to ensure that
the patient would not be able to recall the ratings at the two
occasions.
Validity
Construct validity was tested by comparing the GIQLI score with
the bodily pain scale in SF-36 and the four single-item questions
in patients operated on in the period between October 15, 2005
and October 15, 2006. The four single-item questions were not
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administered during the ﬁrst half of 2005; we therefore per-
formed the validity and reliability analyses on two separate
cohorts. Construct validity was tested in the ratings before
surgery.
The SF-36 is a generic instrument with 36 items. It yields an
eight-scale proﬁle of functional health and well-being scores as
well as psychometrically based physical and mental health
summary measures, and a preference-based health utility index.
As the bodily pain scale is conceptually most closely related to
gallstone-related symptoms, we used this scale for assessing con-
struct validity. The four single-item questions were as follows:
1. Are you troubled by abdominal pain?
2. If you feel pain, please indicate with a cross in the picture
where the pain is located.
3. Do you believe that your troubles are caused by gallstones?
4. Indicate with a cross on the scale below the intensity of the
pain as you perceived it when it was most pronounced
during the past week.
Two of the single-item questions have been presented in a
previous report [7].
Sensitivity to Change
The sensitivity to change of GIQLI was tested in a single-group
design [8] by determining the difference between the score before
surgery and that 6 months postoperatively in the patients oper-
ated on during the period January 1 to August 31, 2005.
Statistics
The test–retest stability was assessed by calculating intraclass
correlation. Intraclass correlation was assessed by comparing
the ratings of each responder; the period elapsed between the
responses was not included in the analysis. Internal consistence
was assessed with Cronbach’s alpha in the questionnaires
recorded before surgery by the same patients. The correlation
between GIQLI and the other symptom measures was tested with
Spearman’s rank correlation coefﬁcient. A factor analysis with
varimax rotation was performed to compare the factor loadings
to the original subscale division.
Results
Response Rates
Altogether 187 patients underwent planned cholecystectomy
during the period between January 1, 2005 and August 31, 2006
(125 women and 62 men, mean age 45.9 years, standard devia-
tion [SD] 15.1 years). The response rate was 32% (59/187) for
the preoperative questionnaire, 59% (110/187) for the question-
naire 6 months after surgery, 47% (87/187) for the questionnaire
12 months after surgery, and 23% (43/187) for the questionnaire
15 months after surgery. Thirty-three (18%) patients completed
all the three follow-up questionnaires. Of the 311 patients who
underwent planned surgery in the period October 15, 2005 to
October 15, 2006, 104 (33%) responded to the questionnaire
before surgery.
Reliability
Test–retest stability was determined from the responses 12 and
15 months after surgery. Intraclass correlation was 0.85 (95%
conﬁdence interval [CI] 0.73–0.92) for the global score, 0.87
(95% CI 0.76–0.93) for symptoms, 0.83 (95% CI 0.70–0.91) for
physical dysfunction, 0.68 (95% CI 0.46–0.81) for emotional
dysfunction, 0.63 (95% CI 0.40–0.79) for social dysfunction,
and 0.62 (95% CI 0.38–0.78) for effect of medical treatment.
Cronbach’s alpha was 0.92 for the global score, 0.89 for symp-
toms, 0.84 for physical dysfunction, 0.83 for emotional dysfunc-
tion, and 0.77 for social dysfunction.
Validity
All domains as well as the overall GIQLI improved 6 months
postoperatively as compared to the scores before surgery
(Table 1). All domains correlated signiﬁcantly with the bodily
pain scale of SF-36 and the question regarding frequency of
abdominal pain (Table 2). Nevertheless, they did not correlate
signiﬁcantly with the question regarding the patient’s own con-
viction of the origin of the pain.
In a factor analysis, applying varimax rotation with 25 itera-
tions, nine factors with eigenvalues greater than 1 accounting for
72% of the variance were found. The factor analysis was repeated
with the number of factors restricted to ﬁve to compare the
outcome to subscale division originally described for GIQLI [4].
This solution accounted for 58% of the variance. Although the
division into ﬁve subscales explained less of the variance than the
division into nine scales, this division allowed for a more compre-
hensive comparison with the original subscale division and gave a
more coherent structure. The division into ﬁve factors could be
interpreted as performance in physical role, large bowel function,
performance in emotional role, upper gastrointestinal tract func-
tion, and meteorism, resembling the original subscale division.
The large bowel function, upper gastrointestinal tract function,
and meteorism in our analysis correspond to symptoms in the
original subscale division, whereas physical role in our subscale
division corresponds to emotions and social dysfunction in the
original division. Items 1, 2, 8, 9, 15, 16, 17, 24, and 29 did not fall
into subscales together with the same items as in the original
subscale division.
Discussion
The high reliability and validity of GIQLI shown in the present
study supports the value of this questionnaire as an instrument
Table 1 GIQLI scores before surgery and 6 months postoperatively
Domain Score before surgery (SD)
Score 6 months postoperatively
(SD) P-value
Symptoms 51.0 (12.7) 58.2 (11.4) <0.001
Physical dysfunction 16.3 (5.9) 19.6 (5.7) <0.001
Emotional dysfunction 11.8 (4.9) 14.8 (3.8) 0.001
Social dysfunction 11.7 (3.7) 13.5 (3.2) 0.002
Effect of medical treatment 4.3 (1.0) 4.6 (0.9) 0.017
GIQLI, overall 95.1 (24.8) 111.8 (20.1) <0.001
GIQLI, Gastrointestinal Quality of Life Index; SD, standard deviation.
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for assessing the impact of gallstone-related symptoms on health-
related quality of life. Further support is provided by results of
previous studies in similar patient groups, which have shown that
GIQLI is applicable in patients with gallstone disease and easy to
administer [4,9,10]. As it covers a broad scale of gastrointestinal
symptoms, the risk of overlooking any manifestations of
gallstone-related syndrome is minimized. It may seem that a
number of items included in the instrument do not obviously
have bearing on gallstone-related symptoms and might hence
reduce its speciﬁcity. Nevertheless, this has not resulted in a
reduction of the sensitivity to change and correlation with other
measures of gallstone-related symptoms, including three of the
single-item questions and SF-36. The high test–retest stability
conﬁrms the reliability of GIQLI.
The high correlation between the GIQLI score and the other
measures of gallstone-related symptoms gives support to the
construct validity of GIQLI (Table 2). The pain was also signiﬁ-
cantly more often localized in the right upper quadrant, although
there was no association between the localization of the pain and
the GIQLI score (Table 3).
The factor analysis gave ﬁve factors the resembled those
devised by the instrument developers, although the factor load-
ings were slightly different (Table 4). As originally devised, sub-
scales with predominantly physical and emotional items could be
identiﬁed. We also found three subscales with gastrointestinal
symptoms (large bowel function, upper gastrointestinal tract
symptoms, and meteorism). The differentiation into three differ-
ent gastrointestinal subscales may reﬂect the speciﬁc characteris-
tics of symptoms in gallstone disease.
Whereas large bowel function symptoms and meteorism are
very common in the whole population, they are not associated
with gallstones. The items that fell in the upper gastrointestinal
tract symptoms are generally considered more strongly associ-
ated with the presence of gallstones. There was, however, a
paradoxically stronger correlation between the bodily pain score
of SF-36 and social dysfunction than between bodily pain and
symptoms (Table 2). Although all correlations were signiﬁcant,
the strong association between the purely physical items in SF-36
and the items related to social dysfunction in GIQLI is difﬁcult to
Table 2 Correlations between GIQLI score and other measures of gallstone-related symptoms
SF-36, bodily pain VAS Abdominal pain frequency
Patient’s conviction on
pain origin
Correlation
coefﬁcient P-value
Correlation
coefﬁcient P-value
Correlation
coefﬁcient P-value
Correlation
coefﬁcient P-value
Symptoms 0.52 <0.001 -0.44 <0.001 -0.57 <0.001 0.03 0.77
Emotions 0.53 <0.001 -0.43 <0.001 -0.45 <0.001 -0.18 0.08
Physical dysfunction 0.52 <0.001 -0.42 <0.001 -0.55 <0.001 -0.08 0.48
Social dysfunction 0.68 <0.001 -0.37 <0.001 -0.58 <0.001 -0.08 0.46
Effect of medical treatment 0.44 <0.001 -0.24 0.017 -0.36 <0.001 -0.11 0.29
Overall GIQLI score 0.63 <0.001 -0.50 <0.001 -0.60 <0.001 -0.08 0.49
GIQLI, Gastrointestinal Quality of Life Index;VAS, visual analogue scale.
Table 3 Pain localization
Quadrant
Patients with pain Patients without pain
Pn GIQLI score (SD) n GIQLI score (SD)
Right upper 63 96 (21) 22 96 (26) 0.23
Left upper 13 101 (18) 72 95 (23) 0.16
Right lower 13 84 (22) 72 99 (22) 0.86
Left lower 5 87 (20) 80 97 (22) 0.81
GIQLI, Gastrointestinal Quality of Life Index; SD, standard deviation.
Table 4 Subscale division and factor loadings after factor analysis with
varimax rotation
GIQLI
item no. Components Loading
Component 1 (physical role)
1 Pain 0.51
18 Appearance 0.74
19 Physical strength 0.71
20 Endurance 0.58
21 Feeling unﬁt 0.54
22 Daily activities 0.72
23 Leisure activities 0.71
24 Bothered by treatment 0.68
25 Worsened relations 0.60
26 Impaired sexual life 0.62
29 Dysphagia 0.60
Eigenvalue 6.2
Variance (%) 17.3
Component 2 (large bowel function)
6 Abdominal noises 0.54
7 Bowel frequency 0.55
30 Bowel urgency 0.78
31 Diarrhea 0.73
34 Blood in stool 0.58
36 Uncontrolled stools 0.66
Eigenvalue 4.7
Variance (%) 13.0
Component 3 (emotional role)
8 Enjoyed eating 0.59
10 Coping with stress 0.65
11 Sadness 0.65
12 Nervous 0.60
13 Happy with life 0.45
14 Frustrated 0.76
15 Fatigue 0.54
16 Feeling unwell 0.56
Eigenvalue 4.4
Variance (%) 12.2
Component 4 (upper gastrointestinal
tract function)
2 Fullness 0.42
9 Restricted eating 0.37
17 Wake up at night 0.66
27 Regurgitation 0.58
28 Eating speed 0.51
32 Constipation 0.70
33 Nausea 0.43
35 Heartburn 0.52
Eigenvalue 3.2
Variance (%) 9.0
Component 5 (meteorism)
3 Bloating 0.65
4 Flatus 0.72
5 Belching 0.43
Eigenvalue 2.5
Variance (%) 6.9
GIQLI, Gastrointestinal Quality of Life Index.
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explain. It may be that frequent attacks of biliary colic may
interfere with the social role as well.
Although the response rate was relatively low in the
follow-up questionnaires as we did not send any reminders, we
do not believe that this has biased the outcome because there is
no obvious reason for a selection mechanism. The patients were
sampled from a population-based register; inclusion was not
dependent on any circumstances related to the extent of symp-
toms or decision to undergo surgery.
In conclusion, the Swedish translation of the GIQLI question-
naire has high reliability and validity. The German and English
versions are already well established, showing that it is applicable
to various populations with gallstone-related symptoms. It can
therefore readily be used as a basis for monitoring the outcome
after gallstone surgery and for clinical trials.
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